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Background: Patent foramen ovale (PFO) is an anatomical interatrial communication with potential 
for right-to-left shunt. It is detected in 10-15% of the population by transthoracic echocardiography 
(TTE) and up to 27% by autopsy. Most patients with isolated PFO are asymptomatic. Patients may have 
a history of stroke or transient ischemic event of undefined etiology.1,2 The recurrence rate of stroke or 
TIA has been reported to be as high as 3.4-3.9% per year. In patients with atrial septal aneurysm and 
PFO, the risk of first recurrent stroke within 2 years has been reported to be as high as 9%, whereas the 
rate of subsequent stroke or TIA recurrence within 2 years increases to 22%. No consensus exists on 
treatment of PFO in patients with transient ischemic attack (TIA) or stroke. Traditional treatment has 
been antiplatelet therapy alone in low-risk patients or combined with warfarin in high-risk individuals 
to prevent cryptogenic stroke.3,4
Case report: We represent three cases of PFO diagnosed in our hospital within past 14 months. Case 
1: 34-year-old man hospitalized at the Neurology Department due to transient loss of consciousness. 
Echocardiography showed interatrial septal aneurysm, and two septal defects – subaortal, 11mm in 
diameter with left-to-right shunt and second one, 3mm in di-
ameter. There was also visible smaller thrombotic mass in left 
auricle. Patient underwent surgical closure. Case 2: 39-year-old 
woman presented at the routine echocardiographic exami-
nation after she was discharged from Neurology department 
where she was treated for stroke. Her brain MRI showed mul-
tiple ischemic infarctions with no focal deficit on neurological 
examination. TTE showed small PFO, 3mm in diameter with 
right-to-left shunt (Figure 1, Figure 2). Patient received percu-
taneous surgical closure. Case 3: 63-year-old man presented to 
the internist after loss of consciousness. ECG showed atrial fi-
brillation and TTE was subsequently performed. It showed atrial 
Figure 2.  Patent foramen ovale with right-to-left shunt.
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Figure 1. Patent foramen ovale.
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Figure 3. Atrial septal aneurysm. Figure 4. Atrial septal defect with left-to-right shunt. 
septal aneurysm, a septal defect, 14mm in diameter with left-to-right shunt (Figure 3, Figure 4). The patient is on the waiting list for 
surgical treatment.   
Conclusion: Surgical closure PFO has resulted in elimination of residual shunt across the PFO. Advantages include the following: per-
manent closure of the defect, prevents future paradoxical emboli, no long-term anticoagulation and its risks.
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